FDA Approves Lilly's Mounjaro (Tirzepatide) To Reduce Cardiovascular Risk In Adults With Type 2 Diabetes
LLY•FDA approves Mounjaro for cardiovascular risk reduction
Aug. 28 (Reuters) - Eli Lilly and Company LLY.N:
LLY•LLY•LLY•Aug. 28 (Reuters) - Eli Lilly and Company LLY.N:
